ArticleFrontiers in endocrinology2025
Associations between inactivated COVID-19 vaccination status and timing and fertility and pregnancy outcomes following frozen-thawed embryo transfer: a prospective cohort study.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Limited evidence exists on the safety of inactivated COVID-19 vaccines and the optimal vaccination timing for women undergoing Methods: This was a single-center prospective cohort study conducted from 1 May to 31 December 2021, with follow-up until 15 November 2022. We studied female patients aged 20 to 47 years undergoing IVF. Participants undergoing their first FET were included in this study. Information on maternal sociodemographic and health-related factors, COVID-19 vaccination status, the IVF-ET process, and outcomes was collected. Generalized linear models or generalized estimating equation models were used to evaluate the associations between vaccination and fertility and pregnancy outcomes. We controlled for maternal characteristics and cycle characteristics, including maternal age, BMI, parity, ovarian stimulation protocol, fertilization method, endometrial preparation, and other relevant factors. Results: A total of 2,733 eligible women were included, with 742 (27.1%) in the vaccinated group and 1,991 (72.9%) in the unvaccinated group. Among these women, 1,367 (50.0%) achieved a live birth. The incidences of clinical pregnancy and live birth were lower in the vaccinated group compared to the unvaccinated group (clinical pregnancy: 56.6% vs. 63.6%; adjusted RR: 0.92, 95% CI: 0.86, 0.98; live birth: 44.3% vs. 52.2%; adjusted RR: 0.89, 95% CI: 0.82, 0.98). These significant associations were more pronounced in women vaccinated before ovarian stimulation (clinical pregnancy: adjusted RR: 0.91, 95% CI: 0.84, 0.98; live birth: adjusted RR: 0.86, 95% CI: 0.78, 0.95), particularly in those with a ≤ 90-day interval between vaccination and ovarian stimulation. The effect size was similar but did not reach statistical significance in women vaccinated after ovarian stimulation and before FET (clinical pregnancy: adjusted RR: 0.92, 95% CI: 0.79, 1.07; live birth: adjusted RR: 0.93, 95% CI: 0.78, 1.12). No significant association was found with pregnancy outcomes. Conclusion: Inactivated COVID-19 vaccination may be associated with a modest reduction in IVF-FET success, particularly when administered before ovarian stimulation. However, a vaccination administered more than 90 days prior to ovarian stimulation may help mitigate these potential adverse effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.